[go: up one dir, main page]

LT2865663T - Naujas indansulfamido darinys - Google Patents

Naujas indansulfamido darinys

Info

Publication number
LT2865663T
LT2865663T LTEP13807707.8T LT13807707T LT2865663T LT 2865663 T LT2865663 T LT 2865663T LT 13807707 T LT13807707 T LT 13807707T LT 2865663 T LT2865663 T LT 2865663T
Authority
LT
Lithuania
Prior art keywords
novel
derivative
indanesulfamide derivative
novel indanesulfamide
indanesulfamide
Prior art date
Application number
LTEP13807707.8T
Other languages
English (en)
Inventor
Yuji Kazuta
Toru Watanabe
Keiichi Sorimachi
Minako Saito
Yoichi Kita
Toshiaki Tanaka
Hiroyuki Higashiyama
Takahisa Hanada
Tetsuyuki Teramoto
Takashi Kosasa
Yukio Ishikawa
Original Assignee
Eisai R&D Management Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co., Ltd. filed Critical Eisai R&D Management Co., Ltd.
Publication of LT2865663T publication Critical patent/LT2865663T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04Diamides of sulfuric acids
    • C07C307/08Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEP13807707.8T 2012-06-21 2013-06-17 Naujas indansulfamido darinys LT2865663T (lt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261662626P 2012-06-21 2012-06-21
US201261709737P 2012-10-04 2012-10-04
US201361751331P 2013-01-11 2013-01-11
PCT/JP2013/066623 WO2013191144A1 (ja) 2012-06-21 2013-06-17 新規インダンスルファミド誘導体

Publications (1)

Publication Number Publication Date
LT2865663T true LT2865663T (lt) 2017-07-10

Family

ID=49768740

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13807707.8T LT2865663T (lt) 2012-06-21 2013-06-17 Naujas indansulfamido darinys

Country Status (34)

Country Link
US (1) US9018260B2 (lt)
EP (1) EP2865663B1 (lt)
JP (1) JP5883135B2 (lt)
KR (1) KR101951519B1 (lt)
CN (1) CN104395285B (lt)
AR (1) AR091506A1 (lt)
AU (1) AU2013278450B2 (lt)
BR (1) BR112014031565B1 (lt)
CA (1) CA2877097C (lt)
CL (1) CL2014003429A1 (lt)
CY (1) CY1119171T1 (lt)
DK (1) DK2865663T3 (lt)
ES (1) ES2628374T3 (lt)
HR (1) HRP20170863T1 (lt)
HU (1) HUE033583T2 (lt)
IL (1) IL236295A (lt)
JO (1) JO3263B1 (lt)
LT (1) LT2865663T (lt)
ME (1) ME02753B (lt)
MX (1) MX355261B (lt)
MY (1) MY169073A (lt)
NZ (1) NZ702974A (lt)
PE (1) PE20150284A1 (lt)
PH (1) PH12014502805B1 (lt)
PL (1) PL2865663T3 (lt)
PT (1) PT2865663T (lt)
RS (1) RS56073B1 (lt)
RU (1) RU2619937C2 (lt)
SG (1) SG11201408359PA (lt)
SI (1) SI2865663T1 (lt)
SM (1) SMT201700287T1 (lt)
TW (1) TWI597263B (lt)
WO (1) WO2013191144A1 (lt)
ZA (1) ZA201409248B (lt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3417851T1 (sl) 2013-09-09 2020-11-30 Peloton Therapeutics, Inc. Aril etri in njihova uporaba
WO2015095048A1 (en) 2013-12-16 2015-06-25 Peloton Therapeutics, Inc. Cyclic sulfone and sulfoximine analogs and uses thereof
CA2932529C (en) * 2013-12-19 2022-03-22 Eisai R&D Management Co., Ltd. Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain
WO2016144825A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
EP3268362B1 (en) 2015-03-11 2021-10-20 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
US10278942B2 (en) 2015-03-11 2019-05-07 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
WO2016145045A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Compositions for use in treating glioblastoma
WO2016168510A1 (en) 2015-04-17 2016-10-20 Peloton Therapeutics, Inc. Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
US9796697B2 (en) 2015-06-12 2017-10-24 Peloton Therapeutics, Inc. Tricyclic inhibitors of HIF-2-alpha and uses thereof
CA3092295A1 (en) * 2018-03-20 2019-09-26 Eisai R&D Management Co., Ltd. Epilepsy treatment agent
JP2024026905A (ja) * 2020-11-25 2024-02-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 てんかん治療剤
US20250195457A1 (en) 2022-04-27 2025-06-19 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treatment of parkinson's disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3383414A (en) 1964-08-26 1968-05-14 Sandoz Ag Benzocycloalkyl sulfamides
US3709677A (en) 1969-06-25 1973-01-09 Sandoz Ag N-substituted sulfamoyl compounds useful as herbicides
WO2003000654A1 (en) * 2001-06-26 2003-01-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Valproyltaurinamide derivatives as anticonvulsant and cns active agents
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
CA2578407A1 (en) * 2004-08-24 2006-03-02 Janssen Pharmaceutica N.V. Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
CN100572365C (zh) * 2006-01-26 2009-12-23 全哲山 用作抗癫痫药的1,2,4-三唑并[4,3-a]喹啉-1-酮衍生物及其可药用盐
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
CL2007002994A1 (es) 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明(cyclopamine)類似物類
AR070949A1 (es) * 2007-10-19 2010-05-19 Solvay Pharm Gmbh Compuestos derivados de sulfamato de uso medico, medicamentos y composiciones farmaceuticas que los comprenden, procedimientos para preparar estos compuestos y su uso
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
CN102365265A (zh) * 2009-04-09 2012-02-29 欧加农股份有限公司 2,3-二氢化茚衍生物
CA2780772C (en) * 2009-11-13 2018-01-16 Receptos, Inc. Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
DK2498609T3 (en) * 2009-11-13 2018-06-18 Celgene Int Ii Sarl SELECTIVE HETEROCYCLIC SPHINGOSIN-1 PHOSPHATRECEPTOR MODULATORS
US20120302546A1 (en) * 2010-02-04 2012-11-29 Fox Chase Chemical Diversity Center, Inc. Novel sulfamides exhibiting neuroprotective action and methods for use thereof
US20120077814A1 (en) * 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives

Also Published As

Publication number Publication date
BR112014031565B1 (pt) 2022-04-12
PH12014502805A1 (en) 2015-02-23
DK2865663T3 (en) 2017-06-19
TW201402530A (zh) 2014-01-16
RU2014151013A (ru) 2016-08-10
ES2628374T3 (es) 2017-08-02
PE20150284A1 (es) 2015-02-21
NZ702974A (en) 2016-03-31
WO2013191144A1 (ja) 2013-12-27
US9018260B2 (en) 2015-04-28
MX2014015492A (es) 2015-05-08
CN104395285A (zh) 2015-03-04
IL236295A0 (en) 2015-02-26
PL2865663T3 (pl) 2017-09-29
CA2877097C (en) 2018-08-07
EP2865663B1 (en) 2017-04-05
AU2013278450B2 (en) 2017-04-20
EP2865663A4 (en) 2016-02-17
BR112014031565A2 (pt) 2017-06-27
JP5883135B2 (ja) 2016-03-09
ME02753B (me) 2018-01-20
CL2014003429A1 (es) 2015-03-27
KR20150032838A (ko) 2015-03-30
SI2865663T1 (sl) 2017-07-31
AR091506A1 (es) 2015-02-11
TWI597263B (zh) 2017-09-01
IL236295A (en) 2016-09-29
CA2877097A1 (en) 2013-12-27
AU2013278450A1 (en) 2015-01-22
PH12014502805B1 (en) 2015-02-23
PT2865663T (pt) 2017-06-02
MX355261B (es) 2018-04-12
SG11201408359PA (en) 2015-01-29
SMT201700287T1 (it) 2017-07-18
HRP20170863T1 (hr) 2017-09-08
US20140371319A1 (en) 2014-12-18
JO3263B1 (ar) 2018-09-16
ZA201409248B (en) 2015-12-23
CY1119171T1 (el) 2018-02-14
HUE033583T2 (hu) 2017-12-28
CN104395285B (zh) 2016-04-13
MY169073A (en) 2019-02-13
BR112014031565A8 (pt) 2021-06-08
JPWO2013191144A1 (ja) 2016-05-26
KR101951519B1 (ko) 2019-02-22
EP2865663A1 (en) 2015-04-29
RS56073B1 (sr) 2017-10-31
HK1207363A1 (en) 2016-01-29
RU2619937C2 (ru) 2017-05-22

Similar Documents

Publication Publication Date Title
ZA201407694B (en) Substituted pyrrolidine-2-carboxamides
GB201304182D0 (en) No details
ZA201409422B (en) Benzimidazole-proline derivatives
SG11201404344XA (en) Substituted pyrrolidine-2-carboxamides
ZA201408876B (en) Pyrrolotriazinone derivatives
ZA201409248B (en) Novel indanesulfamide derivative
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
EP2934541A4 (en) NORIBOGAINE SUBSTITUTE
ZA201405108B (en) Substituted phenylazole derivative
PL2873660T3 (pl) Pochodna indolokarboksyamidu
SG11201404325VA (en) Pyrimidooxazocine derivatives as mtor - inhibitors
GB201207154D0 (en) Novel form
GB201302155D0 (en) No details
GB201300109D0 (en) No details
GB201212393D0 (en) Novel combination
GB201310646D0 (en) No details